AI-Enabled Plasma Center Operations Modernization

Client: CSL Plasma (Contract via CXC Global)
Project Duration: March 2026 – March 2027

Challenge

1

As CSL Plasma explored the adoption of AI-enabled technologies across its plasma center network, the organization launched the “Greenhouse Initiative” to evaluate emerging digital solutions aimed at improving donor experience, operational efficiency, and clinical workflow optimization.

However, introducing AI into regulated healthcare operations presents complex challenges. Before selecting technology vendors, CSL needed clear operational models showing how AI solutions could safely integrate into plasma center workflows.

Key challenges included:

  • Limited visibility into how proposed AI solutions would interact with existing donor intake, scheduling, and screening workflows.

  • The need to evaluate multiple AI vendors against real operational processes rather than abstract technology capabilities.

  • Ensuring that automation opportunities do not compromise regulatory compliance, donor safety, or required human oversight.

Approach

2

1. Foundation – Mapping Current Plasma Center Operations

  • Developed AS-IS operational process maps documenting donor workflows across key plasma center activities including donor scheduling, intake, health screening, eligibility verification, and donation preparation.

  • Identified operational bottlenecks, manual intervention points, and areas of donor friction within existing workflows.

  • Translated complex center procedures into clear, decision-ready process models enabling leadership to understand operational realities before introducing automation.

2. Enablement – Designing AI-Enabled Future-State Workflows

  • Created TO-BE process architectures demonstrating how emerging AI technologies could integrate into plasma center operations.

  • Modeled potential AI-enabled workflows including automated donor scheduling, digital health screening and eligibility assessments, AI-assisted donor triage and intake processes.

  • Developed structured workflows illustrating human oversight checkpoints, ensuring that proposed automation maintains compliance with clinical and regulatory requirements.

3. Growth – Supporting Technology Vendor Evaluation

  • Produced process models used by leadership to evaluate AI vendor capabilities against real operational scenarios.

  • Designed workflow frameworks that helped stakeholders compare vendor functionality, operational integration requirements, compliance considerations risk mitigation strategies.

  • Facilitated collaboration between operations leaders, technology teams, and external vendors to ensure alignment between technology capabilities and operational realities.

Results

3

Operational clarity: Established a clear baseline of plasma center workflows, enabling leadership to assess automation opportunities with confidence.

Vendor evaluation support: Process models provided a structured framework for comparing AI solutions against operational requirements.

Risk mitigation: Future-state workflows incorporated human verification and regulatory checkpoints to ensure donor safety and compliance.

Technology readiness: CSL Plasma gained actionable insight into how AI tools could realistically integrate into plasma center operations.

Decision enablement: Leadership was equipped with operational models that supported strategic decision-making regarding AI adoption.

Impact Statement

4

By developing structured process architectures for CSL Plasma’s AI Greenhouse Initiative, operational workflows were translated into decision-ready models that guided the safe and effective integration of emerging technologies.

This work enabled CSL Plasma to evaluate AI innovations through the lens of real operational processes – ensuring that future technology adoption enhances efficiency and donor experience while maintaining the regulatory rigor required in plasma center operations.